Middle East & Africa Clinical Trial Imaging Market Size & Outlook
Related Markets
MEA clinical trial imaging market highlights
- The MEA clinical trial imaging market generated a revenue of USD 32.8 million in 2024.
- The market is expected to grow at a CAGR of 6.8% from 2025 to 2030.
- In terms of segment, computed tomography scan was the largest revenue generating modality in 2024.
- Magnetic Resonance Imaging is the most lucrative modality segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 32.8 million |
| Market revenue in 2030 | USD 48.4 million |
| Growth rate | 6.8% (CAGR from 2025 to 2030) |
| Largest segment | Computed tomography scan |
| Fastest growing segment | Magnetic Resonance Imaging |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Computed Tomography Scan, Magnetic Resonance Imaging, X-Ray, Ultrasound, Optical Coherence Tomography (OCT), Other Modalities |
| Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.7% of the global clinical trial imaging market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 405.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Imaging Market Scope
Clinical Trial Imaging Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Resonance Health | View profile | 1-10 | Claremont, Western Australia, Australia, Oceania | http://resonancehealth.com |
| Intrinsic Imaging | View profile | 51-100 | Bolton, Massachusetts, United States, North America | http://www.intrinsicimaging.com |
| Cardiovascular Imaging Technologies | View profile | - | Kansas City, Missouri, United States, North America | https://www.cvit.com |
| ProScan Imaging | View profile | 251-500 | Cincinnati, Ohio, United States, North America | http://www.proscan.com/ |
| Clario | View profile | 5001-10000 | Philadelphia, Pennsylvania, United States, North America | https://clario.com/ |
| Ixico | View profile | 51-100 | London, England, United Kingdom, Europe | http://www.ixico.com |
| BioTelemetry | View profile | 1001-5000 | Malvern, Pennsylvania, United States, North America | https://www.gobio.com |
| Navitas Organics | View profile | 51-100 | Novato, California, United States, North America | https://navitasorganics.com/ |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
Middle East & Africa clinical trial imaging market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Computed tomography scan was the largest segment with a revenue share of 27.44% in 2024. Horizon Databook has segmented the Middle East & Africa clinical trial imaging market based on computed tomography scan, magnetic resonance imaging, x-ray, ultrasound, optical coherence tomography (oct), other modalities covering the revenue growth of each sub-segment from 2018 to 2030.
Middle East and North Africa (MENA) remains an extremely under-represented region for clinical trials. Most of the Middle East is part of the advanced world and the remaining region is mainly a part of newly developed economies with established medical infrastructure identical to Eastern Europe.
MEA consists of large Europid population with diseases similar to those in the West, including respiratory diseases, cancer, and cardiovascular diseases.
Increasing demand for medication, growing population, rising incidence of lifestyle-associated diseases & rare diseases in MEA are providing opportunities for conducting clinical trials in this region.
Reasons to subscribe to Middle East & Africa clinical trial imaging market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa clinical trial imaging market databook
-
Our clientele includes a mix of clinical trial imaging market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa clinical trial imaging market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA clinical trial imaging market size, by country, 2018-2030 (US$M)
Middle East & Africa Clinical Trial Imaging Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
